Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
22.52
+0.33 (1.49%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Catalyst Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
163.8971.4183.0839.4874.98
Upgrade
Depreciation & Amortization
37.7732.881.240.190.09
Upgrade
Asset Writedown & Restructuring Costs
-81.51---
Upgrade
Loss (Gain) From Sale of Investments
-5.08-3.020.76--
Upgrade
Stock-Based Compensation
22.2514.257.916.076.26
Upgrade
Other Operating Activities
-9.95-16.119.339.6-32.19
Upgrade
Change in Accounts Receivable
-11.96-43.08-3.82-0.634.55
Upgrade
Change in Inventory
-3.9-4.741.07-3.22-2.69
Upgrade
Change in Accounts Payable
1.810.821.21-1.490.14
Upgrade
Change in Other Net Operating Assets
44.98-0.3315.2810.36-6.11
Upgrade
Operating Cash Flow
239.81143.6116.0560.3745.03
Upgrade
Operating Cash Flow Growth
67.00%23.74%92.22%34.06%30.11%
Upgrade
Capital Expenditures
-0.56-198.52-10.03-1.02-0.01
Upgrade
Sale (Purchase) of Intangibles
--81.51---
Upgrade
Investment in Securities
--13.4719.24-10-5
Upgrade
Investing Cash Flow
-0.56-293.59.21-11.02-5.01
Upgrade
Issuance of Common Stock
154.522.799.574.10.76
Upgrade
Repurchase of Common Stock
-0.67-0.98-7.14-12.24-0.06
Upgrade
Other Financing Activities
-13.18-12.67-0.74--
Upgrade
Financing Cash Flow
140.67-10.861.69-8.140.7
Upgrade
Net Cash Flow
379.92-160.76126.9541.2140.73
Upgrade
Free Cash Flow
239.25-54.92106.0259.3545.02
Upgrade
Free Cash Flow Growth
--78.63%31.82%30.15%
Upgrade
Free Cash Flow Margin
48.66%-13.79%49.49%42.14%37.81%
Upgrade
Free Cash Flow Per Share
1.92-0.480.950.550.42
Upgrade
Cash Income Tax Paid
---32.79
Upgrade
Levered Free Cash Flow
201.64-219.4989.6942.1428.96
Upgrade
Unlevered Free Cash Flow
201.64-219.4989.6942.1428.96
Upgrade
Change in Net Working Capital
-20.2240.84-26.93-4.153.19
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q